Millennium BioTherapeutics Inc., Harvard Medical School deal

Millennium BioTherapeutics, a subsidiary of Millennium Pharmaceuticals Inc. (MLNM, Cambridge, Mass.), will allow medical school researchers access to its genes, proteins, antibodies and other biologi...